New treatment approaches induce responses in unresectable intrahepatic cholangiocarcinoma

Chemotherapy combined with hepatic arterial infusion of floxuridine or with selective internal radiotherapy induced antitumor activity among patients with unresectable intrahepatic cholangiocarcinoma, according to results of separate phase 2 studies published in JAMA Oncology.Both regimens appeared safe. Additionally, a high proportion of patients who underwent selective internal radiotherapy and chemotherapy as first-line treatment were downstaged to surgical intervention, with favorable outcomes.“Intrahepatic cholangiocarcinoma is an uncommon disease in the United States and has aRead More

Share on facebook
Share on twitter
Share on linkedin